We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 43

FDA to Hold Public Hearing on Youth E-Cigarette Cessation
  • Troutman Sanders LLP
  • USA
  • November 13 2018

On December 5, 2018, FDA will hold a public hearing to discuss its efforts to eliminate youth e-cigarette and other tobacco product use. One of the


Public Health Groups Urge Court to Reject FDA’s Proposed Schedule for Graphic Health Warnings
  • Troutman Sanders LLP
  • USA
  • October 30 2018

Last month, the U.S. District Court for the District of Massachusetts found that FDA “unlawfully withheld” and “unreasonably delayed” the


FDA Public Meeting on Tobacco Product Application Review
  • Troutman Sanders LLP
  • USA
  • October 18 2018

On October 22-23, 2018, the Food and Drug Administration will hold a public meeting on the tobacco product application review process. More


FDA Secures Additional Time to Submit Court-Compelled Expedited Schedule for a Final Graphic Health Warnings Rule
  • Troutman Sanders LLP
  • USA
  • September 28 2018

As a follow-up to our earlier blog post on this topic, the FDA now has until October 5, 2018 to provide an expedited schedule for the issuance of a


Federal Court Forces FDA’s Hand on Graphic Warning Labels
  • Troutman Sanders LLP
  • USA
  • September 7 2018

This week, in a rare instance of a court directing a federal agency to take action, the U.S. District Court for the District of Massachusetts ordered


FDA Announces its Plans to Issue Tobacco Product Application “Foundational” Rules
  • Troutman Sanders LLP
  • USA
  • August 27 2018

To mark the nine-year anniversary of the Family Smoking Prevention and Tobacco Control Act and the one-year anniversary of FDA’s Comprehensive Plan


Deeming Regulations Litigation UpdateUncertain Path Ahead for Dual Cigar-Industry Challenges Pending at the Trial Level; Appellate Proceedings Moving Forward
  • Troutman Sanders LLP
  • USA
  • August 19 2018

With a related appeal pending in the U.S. Court of Appeals for the D.C. Circuit, what will become of pending trial litigation in Cigar Association of


Deeming Regulations Litigation Update-U.S. District Court for the District of Columbia Expected Forum for Three Appointments Clause Challenges
  • Troutman Sanders LLP
  • USA
  • July 30 2018

The FDA has advanced in its “procedural maneuvering” in three constitutional challenges to the Deeming Regulations. The challenges - premised on the


Deeming Regulations Litigation Update - Cigar Industry Plaintiffs Seek Stay of Health Warning Requirements Pending Appeal
  • Troutman Sanders LLP
  • USA
  • June 18 2018

The United States Food and Drug Administration recently obtained summary judgment on several cigar industry claims challenging the FDA’s Deeming


Deeming Regulations Litigation Update-Motion to Transfer Cigar Challenge Denied, Appealed by FDA
  • Troutman Sanders LLP
  • USA
  • June 11 2018

U.S. Magistrate Judge Kimberly C. Priest Johnson has denied a motion to transfer the Deeming Regulations challenge in En Fuego Tobacco Shop LLC, et al